Lupin Allots 36,752 Equity Shares Under ESOP, Paid-Up Capital Rises to ₹91,44,31,726

AI Summary

Lupin Limited, on May 4, 2026, allotted 36,752 fully paid-up equity shares of ₹2/- each under its Employee Stock Option plans, following the exercise of vested options by employees and subsidiary staff. The allotment was approved by the company's Operations and Finance Committee at its meeting on the same date. As a result, the company's issued and paid-up share capital has increased to ₹91,44,31,726, comprising 45,72,15,863 equity shares of ₹2/- each. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

powered by

Lupin Limited allotted 36,752 fully paid-up equity shares of ₹2/- each on May 4, 2026, pursuant to the exercise of vested options granted to employees of the company and its subsidiaries. The allotment was approved by the Operations and Finance Committee at its meeting held on May 4, 2026, and was disclosed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

ESOP Allotment Details

The shares were allotted under the company's Stock Option plans, following the exercising of vested options by eligible employees. The key parameters of this allotment are summarised below:

Parameter: Details Allotment Date: May 4, 2026 Number of Shares Allotted: 36,752 Face Value per Share: ₹2/- Allotting Authority: Operations and Finance Committee Scheme: Stock Option Plans (ESOP) Beneficiaries: Employees of the company and its subsidiaries

Impact on Share Capital

Following the allotment, the issued and paid-up share capital of Lupin Limited has been revised upward. The updated capital structure is as follows:

Capital Parameter: Post-Allotment Figure Total Paid-Up Share Capital: ₹91,44,31,726 Total Number of Equity Shares: 45,72,15,863 Face Value per Share: ₹2/-

The disclosure was made by Amit Kumar Gupta, Company Secretary and Compliance Officer, on behalf of Lupin Limited, in accordance with applicable listing regulations.

Lupin Limited has officially announced its earnings call for the fourth quarter of fiscal year 2026, demonstrating its commitment to transparent stakeholder communication and regulatory compliance.

Earnings Call Schedule

The pharmaceutical company has scheduled its Q4 FY26 earnings call with specific timing and platform details to ensure broad stakeholder participation.

Parameter: Details Date: May 8, 2026 (Friday) Time: 16:00 hrs IST Platform: Zoom Call Registration: Required in advance Recommended Join Time: 15:55 hrs IST

Regulatory Compliance

The earnings call announcement was made in strict adherence to Indian securities regulations. Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, the company has formally notified both major Indian stock exchanges about this quarterly disclosure event.

The notification was digitally signed by Amit Kumar Gupta, Company Secretary & Compliance Officer (ACS-15754), ensuring proper authorization and documentation of the regulatory filing. The official communication was filed on April 23, 2026.

Stakeholder Access

Lupin has provided multiple access methods for stakeholders to participate in the earnings call:

Digital Registration: Online registration link provided for Zoom access

QR Code Access: Quick response code available for mobile device registration

Advance Registration: Participants advised to register before the scheduled time

Early Join Recommendation: Stakeholders encouraged to join by 15:55 hrs IST

Exchange Notifications

The company has formally communicated the earnings call schedule to both primary Indian stock exchanges, maintaining transparency in its disclosure obligations.

Exchange: Details NSE Symbol: LUPIN BSE Scrip Code: 500257 (Equity) Filing Date: April 23, 2026 Regulation: SEBI Listing Regulations 2015

This scheduled earnings call represents Lupin's ongoing commitment to maintaining regular communication with investors, analysts, and other stakeholders regarding its quarterly financial performance and business developments.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.